4-[4-[4-ethyl-2-fluoro-5-[(6-methoxypyridazin-3-yl)methyl]phenyl]pyrido[3,2-d]pyrimidin-7-yl]morpholine
C25H25FN6O2 — CID 144744876
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-[4-ethyl-2-fluoro-5-[(6-methoxypyridazin-3-yl)methyl]phenyl]pyrido[3,2-d]pyrimidin-7-yl]morpholine
4-[4-[4-ethyl-2-fluoro-5-[(6-methoxypyridazin-3-yl)methyl]phenyl]pyrido[3,2-d]pyrimidin-7-yl]morpholine (PubChem CID 144744876) has the molecular formula C25H25FN6O2 and a molecular weight of 460.51 g/mol. Its IUPAC name is 4-[4-[4-ethyl-2-fluoro-5-[(6-methoxypyridazin-3-yl)methyl]phenyl]pyrido[3,2-d]pyrimidin-7-yl]morpholine.
Molecular Properties
| Compound Name | 4-[4-[4-ethyl-2-fluoro-5-[(6-methoxypyridazin-3-yl)methyl]phenyl]pyrido[3,2-d]pyrimidin-7-yl]morpholine |
|---|---|
| PubChem CID | 144744876 |
| Molecular Formula | C25H25FN6O2 |
| Molecular Weight | 460.51 g/mol |
| Exact Mass | 460.20 |
| IUPAC Name | 4-[4-[4-ethyl-2-fluoro-5-[(6-methoxypyridazin-3-yl)methyl]phenyl]pyrido[3,2-d]pyrimidin-7-yl]morpholine |
| SMILES | CCc1cc(F)c(-c2ncnc3cc(N4CCOCC4)cnc23)cc1Cc1ccc(OC)nn1 |
| InChI | InChI=1S/C25H25FN6O2/c1-3-16-12-21(26)20(11-17(16)10-18-4-5-23(33-2)31-30-18)24-25-22(28-15-29-24)13-19(14-27-25)32-6-8-34-9-7-32/h4-5,11-15H,3,6-10H2,1-2H3 |
| InChIKey | PFWRAHDMYVSBLY-UHFFFAOYSA-N |
| XLogP | 3.62 |
| TPSA | 86.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 460.51 |
| LogP ≤ 5 | 3.62 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144744876 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.